Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways

Journal of Molecular Histology

Volumn 44, Issue 3, 2013, Pages 357-367

  Zhou, Heng ^a,b   Yang, He Xin ^a,b   Yuan, Yuan ^a,b   Deng, Wei ^a,b   Zhang, Jie Yu ^a,b   Bian, Zhou Yan ^a,b   Zong, Jing ^a,b   Dai, Jia ^a,b   Tang, Qi Zhu ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cardiac remodeling; Fibrosis; Inflammation; Paeoniflorin

Indexed keywords

CASPASE 3; CD68 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONNECTIVE TISSUE GROWTH FACTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PAEONIFLORIN; PROTEIN BAX; SMAD PROTEIN; SMAD2 PROTEIN; SYNAPTOTAGMIN I; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SURGERY; APOPTOSIS; ARTICLE; CARDITIS; CELL COUNT; COLLAGEN METABOLISM; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART WEIGHT; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SURVIVAL RATE; TISSUE LEVEL; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BENZOATES; BIOLOGICAL MARKERS; BRIDGED COMPOUNDS; CARDIOMEGALY; FIBROSIS; GLUCOSIDES; HEART; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NF-KAPPA B; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

MUS;

EID: 84877749266     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-013-9491-x     Document Type: Article

References (35)

1. Asakura M, Kitakaze M (2009) Global gene expression profiling in the failing myocardium. Circ J 73(9):1568-1576
2. Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8(1):30-41
3. Cao W, Zhang W, Liu J, Wang Y, Peng X, Lu D, Qi R, Wang H (2011) Paeoniflorin improves survival in LPS-challenged mice through the suppression of TNF-alpha and IL-1beta release and augmentation of IL-10 production. Int Immunopharmacol 11(2):172-178
4. Chu D, Luo Q, Li C, Gao Y, Yu L, Wei W, Wu Q, Shen J (2007) Paeoniflorin inhibits TGF-beta1-mediated collagen production by Schistosoma japonicum soluble egg antigen in vitro. Parasitology 134(Pt 11):1611-1621
5. Chu D, Du M, Hu X, Wu Q, Shen J (2011) Paeoniflorin attenuates schistosomiasis japonica-associated liver fibrosis through inhibiting alternative activation of macrophages. Parasitology 138(10):1259-1271
6. Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling - concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35(3):569-582
7. Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89(2):265-272
8. Dorn GW 2nd (2009) Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res 81(3):465-473
9. Euler-Taimor G, Heger J (2006) The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 69(1):15-25
10. Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J (2011) New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 58(18):1833-1843
11. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132(3):344-362
12. Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358(13):1370-1380
13. Hutchinson KR, Guggilam A, Cismowski MJ, Galantowicz ML, West TA, Stewart JA Jr, Zhang X, Lord KC, Lucchesi PA (2011) Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol 111(6):1778-1788
14. Ji Q, Yang L, Zhou J, Lin R, Zhang J, Lin Q, Wang W, Zhang K (2012) Protective effects of paeoniflorin against cobalt chloride-induced apoptosis of endothelial cells via HIF-1alpha pathway. Toxicol In Vitro 26(3):455-461
15. Jiang B, Qiao J, Yang Y, Lu Y (2012) Inhibitory effect of paeoniflorin on the inflammatory vicious cycle between adipocytes and macrophages. J Cell Biochem 113(8):2560-2566
16. Jones WK, Brown M, Ren X, He S, McGuinness M (2003) NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol 3(3):229-254
17. Kehat I, Molkentin JD (2010) Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122(25):2727-2735
18. Kim ID, Ha BJ (2010) The effects of paeoniflorin on LPS-induced liver inflammatory reactions. Arch Pharm Res 33(6):959-966
19. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA (2011) Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121(6):2301-2312
20. Li X, Shen J, Zhong Z, Wen H, Luo Q, Wei W (2009) Paeoniflorin: a monomer from traditional Chinese medical herb ameliorates Schistosoma japonicum egg-induced hepatic fibrosis in mice. J Parasitol 95(6):1520-1524
21. Li JZ, Yu SY, Wu JH, Shao QR, Dong XM (2012) Paeoniflorin protects myocardial cell from doxorubicin-induced apoptosis through inhibition of NADPH oxidase. Can J Physiol Pharmacol 90(12):1569-1575
22. Liu Q, Chen Y, Auger-Messier M, Molkentin JD (2012) Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling. Circ Res 110(8):1077-1086
23. Manabe I, Shindo T, Nagai R (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91(12):1103-1113
24. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91(11):988-998
25. Nizamutdinova IT, Jin YC, Kim JS, Yean MH, Kang SS, Kim YS, Lee JH, Seo HG, Kim HJ, Chang KC (2008) Paeonol and paeoniflorin, the main active principles of Paeonia albiflora, protect the heart from myocardial ischemia/reperfusion injury in rats. Planta Med 74(1):14-18
26. Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378(9792):704-712
27. Steenman M, Chen YW, Le Cunff M, Lamirault G, Varro A, Hoffman E, Leger JJ (2003) Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 12(2):97-112
28. Wankun X, Wenzhen Y, Min Z, Weiyan Z, Huan C, Wei D, Lvzhen H, Xu Y, Xiaoxin L (2011) Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro. Mol Vis 17:3512-3522
29. Wei L (2011) Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis. Exp Mol Pathol 90(1):74-78
30. Whelan RS, Kaplinskiy V, Kitsis RN (2010) Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 72:19-44
31. Yan L, Wei X, Tang QZ, Feng J, Zhang Y, Liu C, Bian ZY, Zhang LF, Chen M, Bai X, Wang AB, Fassett J, Chen Y, He YW, Yang Q, Liu PP, Li H (2011) Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3beta and TGF-beta1-Smad signalling. Cardiovasc Res 92(1):85-94
32. Yang HO, Ko WK, Kim JY, Ro HS (2004) Paeoniflorin: an antihyperlipidemic agent from Paeonia lactiflora. Fitoterapia 75(1):45-49
33. Zhou H, Bian D, Jiao X, Wei Z, Zhang H, Xia Y, He Y, Dai Y (2011a) Paeoniflorin protects against lipopolysaccharide-induced acute lung injury in mice by alleviating inflammatory cell infiltration and microvascular permeability. Inflamm Res 60(10):981-990
34. Zhou H, Shen DF, Bian ZY, Zong J, Deng W, Zhang Y, Guo YY, Li H, Tang QZ (2011b) Activating transcription factor 3 deficiency promotes cardiac hypertrophy, dysfunction, and fibrosis induced by pressure overload. PLoS ONE 6(10):e26744
35. Zhou H, Bian ZY, Zong J, Deng W, Yan L, Shen DF, Guo H, Dai J, Yuan Y, Zhang R, Lin YF, Hu X, Li H, Tang QZ (2012) Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload. Hypertension 60(3):802-809